Your browser doesn't support javascript.
loading
Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.
Singh, Balwinder; MahmoudianDehkordi, Siamak; Voort, Jennifer L Vande; Han, Xianlin; Port, John D; Frye, Mark A; Kaddurah-Daouk, Rima.
Afiliação
  • Singh B; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States. Electronic address: singh.balwinder@mayo.edu.
  • MahmoudianDehkordi S; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States.
  • Voort JLV; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Han X; University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
  • Port JD; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States.
  • Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Kaddurah-Daouk R; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States; Department of Medicine, Duke University, Durham, NC, United States; Duke Institute of Brain Sciences, Duke University, Durham, NC, United States.
Psychiatry Res ; 314: 114655, 2022 08.
Article em En | MEDLINE | ID: mdl-35738038

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Psychiatry Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Psychiatry Res Ano de publicação: 2022 Tipo de documento: Article